How should I manage a 3‑year‑old with three days of persistent vomiting, abdominal pain, resolved fever, no abdominal tenderness, who was previously given an anti‑emetic injection and ranitidine (ranitidine) syrup?

Management of Persistent Vomiting in a 3-Year-Old

Focus on oral rehydration therapy (ORS) as the primary intervention, assess hydration status carefully, and consider ondansetron only if the child cannot tolerate oral intake despite proper ORS administration. 1

Immediate Assessment Priorities

Evaluate hydration status systematically:

• Capillary refill time (abnormal if >2 seconds)
• Skin turgor (pinch test on abdomen)
• Mental status (alertness, irritability)
• Urine output (decreased frequency indicates dehydration)
• Mucous membranes (dry vs. moist)

The absence of abdominal tenderness and resolved fever are reassuring signs that reduce concern for surgical emergencies like appendicitis or intussusception 2, 3. However, three days of persistent vomiting warrants careful dehydration assessment even without fever.

Hydration Management Algorithm

If Mild to Moderate Dehydration (3-9% fluid deficit):

Administer ORS 50-100 mL/kg over 3-4 hours 1

• For a 3-year-old (~15 kg): approximately 750-1500 mL over 3-4 hours
• Give small, frequent volumes (5 mL every 1-2 minutes initially) 4
• Use a spoon or syringe for controlled administration
• Replace ongoing losses: 60-120 mL ORS for each vomiting episode 1

Key principle: The previous treatment with ranitidine (Rantac syrup) was inappropriate for acute gastroenteritis-related vomiting. Ranitidine is an H2-receptor antagonist indicated for acid-related disorders, not for vomiting control in gastroenteritis 5. This likely explains why symptoms recurred.

If Severe Dehydration (≥10% deficit):

• Immediate IV isotonic crystalloid boluses (20 mL/kg lactated Ringer's or normal saline)
• Continue until pulse, perfusion, and mental status normalize 1
• Then transition to ORS for remaining deficit replacement

Antiemetic Consideration

Ondansetron may be considered ONLY if:

• The child cannot tolerate oral intake despite proper ORS technique
• Persistent vomiting prevents adequate hydration
• Dose: 0.15 mg/kg IV or 0.2 mg/kg oral (maximum 4 mg) 2

Important caveats about ondansetron:

• Guidelines state it "may be given" to children >4 years, but this child is only 3 years old 1
• No routine recommendation exists for children <4 years 1
• Evidence shows ondansetron reduces immediate vomiting and IV rehydration needs but may increase diarrhea 6, 7
• Does not reduce hospitalization at 72 hours 1
• Antiemetics are NOT a substitute for fluid therapy 1

The meta-analysis by 6 found ondansetron most effective for cessation of vomiting (OR 0.28), but this must be weighed against the child's age being below the guideline-recommended threshold.

Dietary Management

Resume age-appropriate diet immediately after rehydration 1

• Continue normal foods: starches, cereals, yogurt, fruits, vegetables 4
• Avoid foods high in simple sugars and fats 4
• Do not withhold solid food for 24 hours (no evidence of benefit) 1

Red Flags Requiring Urgent Evaluation

Watch for:

• Bilious (green) vomiting (suggests intestinal obstruction)
• Bloody vomitus
• Severe abdominal distension or tenderness
• Altered mental status or lethargy
• Signs of severe dehydration (sunken eyes, no tears, no urine >8 hours)
• Worsening abdominal pain

These would necessitate immediate surgical consultation and imaging 2, 3.

Practical Management Plan

1. Assess hydration status now using clinical parameters above
2. Start ORS immediately with small frequent volumes (5 mL every 1-2 minutes)
3. Replace each vomiting episode with 60-120 mL additional ORS
4. Resume normal diet once tolerating fluids
5. Avoid ranitidine (inappropriate for this indication)
6. Consider ondansetron cautiously only if ORS fails and child cannot maintain hydration, recognizing age is below typical guideline threshold
7. Monitor closely for red flag signs requiring escalation

Most cases of gastroenteritis-related vomiting resolve with proper ORS administration alone 1. The key is patience with small-volume, frequent administration rather than pharmacologic intervention.